TriNetX’s Post

The FDA’s draft guidance on Diversity Action Plans pushes sponsors to rethink protocol templates and inclusion criteria for better trial representation. The key? Leveraging EHR data and #AI to design smarter, more inclusive studies. Learn how this shift is shaping the future of clinical trials: https://ow.ly/CGwm50UrTbO

With new diversity guidance, EHR data plus AI will be critical - TriNetX

With new diversity guidance, EHR data plus AI will be critical - TriNetX

https://trinetx.com

Bilkis Amthaniwala

Regulatory Affairs and Quality Control Enthusiast | MSc in Pharmaceutical Analysis | Driven to Ensure Compliance and Quality Excellence

5d

Diversity is crucial for better trial results!

Like
Reply

To view or add a comment, sign in

Explore topics